Pre- and Posttreatment With Edaravone Protects CA1 Hippocampus and Enhances Neurogenesis in the Subgranular Zone of Dentate Gyrus After Transient Global Cerebral Ischemia in Rats

Abstract

Edaravone is clinically used for treatment of patients with acute cerebral infarction. However, the effect of double application of edaravone on neurogenesis in the hippocampus following ischemia remains unknown. In the present study, we explored whether pre- and posttreatment of edaravone had any effect on neural stem/progenitor cells (NSPCs) in the subgranular zone of hippocampus in a rat model of transient global cerebral ischemia and elucidated the potential mechanism of its effects. Male Sprague-Dawley rats were divided into three groups: sham-operated (n = 15), control (n = 15), and edaravone-treated (n = 15) groups. Newly generated cells were labeled by 5-bromo-2-deoxyuridine. Immunohistochemistry was used to detect neurogenesis. Terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick-end labeling was used to detect cell apoptosis. Reactive oxygen species (ROS) were detected by 2,7-dichlorofluorescien diacetate assay in NSPCs in vitro. Hypoxia-inducible factor-1α (HIF-1α) and cleaved caspase-3 proteins were quantified by western blot analysis. Treatment with edaravone significantly increased the number of NSPCs and newly generated neurons in the subgranular zone (p < .05). Treatment with edaravone also decreased apoptosis of NSPCs (p < .01). Furthermore, treatment with edaravone significantly decreased ROS generation and inhibited HIF-1α and cleaved caspase-3 protein expressions. These findings indicate that pre- and posttreatment with edaravone enhances neurogenesis by protecting NSPCs from apoptosis in the hippocampus, which is probably mediated by decreasing ROS generation and inhibiting protein expressions of HIF-1α and cleaved caspase-3 after cerebral ischemia.

Activation of Type 4 Metabotropic Glutamate Receptor Attenuates Oxidative Stress-Induced Death of Neural Stem Cells with Inhibition of JNK and p38 MAPK Signaling

“…NSCs are exquisitely sensitive to oxidative stress and related damages, which obstructs the normal cellular functions and even leads to cell apoptosis [2,44]. It is suggested that the enhancement of ROS scavenging capacity or the increase of cellular antioxidant mechanisms might facilitate not only the survival of NSCs in disease conditions, but may also regulate their fate [44][45][46]. Our experimental results provide data to support FIG.…”

Nanotubes impregnated human olfactory bulb neural stem cells promote neuronal differentiation in Trimethyltin‐induced neurodegeneration rat model

“…Neural stem cells (NSCs) are multipotent cells resides in different brain regions such as sub ventricular, and sub granular zone of hippocampus (Lei et al, ), and they hold a great opportunity for the future of treatments of neurodegenerative diseases such as AD, PD, ALS, and MS (Ehnert et al, ).…”

Assessment of global ischemic/reperfusion and Tacrolimus administration on CA1 region of hippocampus: gene expression profiles of BAX and BCL2 genes

“…Global cerebral ischemia is a clinical outcome of cardiac arrest, severe hypotension, or certain operations such as cardiopulmonary bypass and cerebral intervention, which deprive the brain of oxygen and glucose. It causes severe damage to pyramidal neurons of the CA1 region and usually results in residual neurological defi cits following a recovery from ischemia (5).…”